United States: U.S. Supreme Court Limits Jurisdictions Where Non-U.S. Businesses May Be Sued

Last Updated: July 6 2017
Article by Antitrust Watch

Authored by Robert Reznick and Elena Kamenir

On June 19, 2017, the U.S. Supreme Court decided Bristol-Myers Squibb Co. v. Superior Court of California,[1] a multi-plaintiff State product liability case in which the Court rejected a loose standard for personal jurisdiction for claims brought by out-of-State plaintiffs. Though questions as to its impact remain, BMS surely will signal the end to multi-State plaintiffs' efforts to centralize claims in the State court of their choosing. Even beyond this, the decision has potentially significant implications for State class actions and perhaps even federal antitrust cases.


Eighty-six California residents and 592 residents from 33 other U.S. States sued the drug maker Bristol-Myers Squib (BMS) in a single non-class action in California.[2]  All alleged injury from ingestion of a drug that they argued had been promoted and sold through a national marketing campaign.  The drug was not developed or manufactured in California, and the campaign was neither designed in nor supervised from California. BMS argued that the claims of the 592 plaintiffs who were not California residents should be dismissed because they lacked any connection with California, and that a California court thus could not assert jurisdiction over the company under the Due Process Clause of the Fourteenth Amendment of the U.S. Constitution.[3]  The California Supreme Court disagreed, but the U.S. Supreme Court agreed with the BMS and limited the case to the 86 California plaintiffs.

The case involved the standards for a court's assertion of personal jurisdiction—the ability of a court to require a defendant to participate in a case and to order relief if warranted.  Two types of personal jurisdiction exist.  First, "general" personal jurisdiction over a defendant is very broad:  it can support a claim brought by any plaintiff no matter where located and no matter where the conduct giving rise to a claim occurred.  General personal jurisdiction over BMS did not exist in California because the U.S. Supreme Court's 2015 Daimler decision essentially limited that type of jurisdiction to States where a corporate defendant is incorporated or has its principal place of business, neither of which was California in the case of BMS.[4]  By contrast, "specific" personal jurisdiction may generally be asserted over a defendant in any U.S. State (i) with which the defendant had "minimum contacts" and (ii) where the "conduct giving rise" to the claim occurred.[5]  (Forcing the defendant to defend against a claim must also satisfy a third "fairness" requirement, which usually is satisfied where the first two requirements are met.)

Specific personal jurisdiction concededly existed as to the California plaintiffs, but the non-California plaintiffs' claims did not arise from the company's contacts with California; while BMS conducted research in California, that work was unrelated to the drug that allegedly caused the plaintiffs' injuries.[6]  BMS likewise admitted that it had contracted with a California distributor to resell its drugs, but argued that neither the act of contracting nor the distributor's subsequent activities elsewhere established the required connection between California and the claims of out-of-State plaintiffs.[7]

The California Supreme Court disagreed.  It applied a "sliding scale" test under which the greater a defendant's contacts with California, whether or not related to the plaintiffs' claims, the less factual connection would be required between those contacts and a plaintiff's claims for specific personal jurisdiction to exist.[8]  Applying this "sliding scale," the Court first concluded that BMS's California research activities were substantial.[9]  That permitted a reduced showing to establish the required connection between the out-of-State plaintiffs and California. The Court found that connection on the ground that the claims of all plaintiffs, no matter where located, were based on the same alleged conduct.

In an 8-to-1 decision, the U.S. Supreme Court rejected the California Supreme Court's expansive "sliding scale" rule of specific personal jurisdiction.[10]  The U.S. Supreme Court held that specific jurisdiction required each and every plaintiff's claim to have arisen from conduct by BMS in California, without reference to whatever other contacts BMS may or may not have had with California.[11]  Because BMS did not develop or make the drug in California, and marketing of the drug likewise was implemented elsewhere, the 592 non-California plaintiffs could not assert specific personal jurisdiction over BMS, and their claims were dismissed. In reaching this conclusion, the U.S. Supreme Court rejected the contention that specific personal jurisdiction could be based on BMS's having engaged a California distributor, potentially for sales in States where non-California plaintiffs resided.  Even if evidence showed that the distributor supplied the pills taken by the out-of-State plaintiffs, the "bare fact" that BMS contracted with a California company could not in any event fairly be said to have "give[n] rise to the claims," nor could the distributor's activities in California be attributed to BMS.[12]  The result, in the Court's view, was that the only locations where BMS could be sued by all of the plaintiffs together were the two jurisdictions outside of California where general personal jurisdiction could be established: the States where the company is incorporated and where it has its principal place of business.

Justice Sotomayor, the lone dissenter, disagreed with the majority on largely policy grounds. She believed the Court's precedents did not preclude personal jurisdiction over defendants in States where they had substantial activities, and argued that the touchstone of personal jurisdiction should remain the Court's seminal International Shoe decision in 1945, which provided simply that the assertion of jurisdiction complies with constitutional requirements so long as it comports with "fair play and substantial justice."[13]  Justice Sotomayor argued that standard was met by BMS's substantial California activities, which demonstrated—to use the parlance of one strand of more recent specific personal jurisdiction law—that the company had "purposefully availed" itself of the benefit of California law, and so may fairly be held to account for its actions in California courts.[14]  She criticized the majority's rule as serving no practical purpose other than to benefit corporate defendants.  She noted that under the Court's decision, foreign corporations that likely are not subject to general personal jurisdiction anywhere in the United States may not be subject to personal jurisdiction in any single state for "nationwide mass actions" arising from their conduct.  Finally, she sought to limit its scope by saying that the case had no applicability to class actions that might be brought on behalf of a class including plaintiffs whose claims had no connection with the forum.

Application to Antitrust Claims and Beyond

  Although decided in the context of a multi-plaintiff state product liability case, the BMS decision applied the Fourteenth Amendment's Due Process Clause, and so should be directly applicable to all State court actions, including those brought under State antitrust laws. State antitrust laws are important nationally because about half of the States have enacted Illinois Brick repealer statutes to enable indirect purchasers to bring antitrust damages claims under state law even though they cannot bring those same claims under the Sherman Act. It should not be surprising to see courts apply BMS in the same manner in the context of non-class action indirect purchaser claims.

That said, certain cautions should be noted. Defendants always can be sued for conduct affecting the United States as a whole in jurisdictions where they are subject to general personal jurisdiction—i.e., where they are incorporated and have their principal places of business. And seemingly even after BMS, companies will be amenable to suit in jurisdictions where they have engaged in conduct allegedly giving rise to injuries nationwide. Some would also argue that, where multiple defendants are involved, allegations of conspiracy may broaden the geographic reach of state lawsuits.[15] However, that assertion has been called into question.[16]

The question whether BMS will be extended to class actions also bears on the size and number of State antitrust claims a defendant may face, and how the resultant changes in financial incentives would alter the shape of litigation. There is California federal court precedent, for example, to the effect that personal jurisdiction with respect to the claims of out-of-State indirect purchaser plaintiffs need only be considered if the law in the plaintiffs' home States differs.[17] To the extent BMS is found applicable to class actions, that holding would appear no longer to be good law.

The Court's majority reserved judgment on whether a different rule for specific personal jurisdiction would apply to certain claims brought in federal court based on alleged violations of federal law—those implicating due process under the Fifth Amendment. The ruling's effect on federal antitrust claims remains a close question.  At least where the claim implicates a federal statute that provides for "nationwide service of process" (including the antitrust laws, as well as the securities laws and RICO, for example), courts have historically recognized some differences in jurisdictional principles, as issues regarding the sovereign rights of individual States are not presented.  In such cases, personal jurisdiction is generally assessed under the Fifth Amendment, not the Fourteenth Amendment, and the relevant constitutional question is whether a defendant's contacts with the United States as a whole, not with the particular forum State, are sufficient to satisfy Due Process requirements of fairness.[18]  Because the Court's analysis in BMS specifically reserved the question whether its analysis would apply under Fifth Amendment due process principles, the issue remains open.  It certainly is the case that much reasoning in the opinion is rooted in concerns over the limits of particular States' sovereignty that would not apply in federal antitrust cases.

Another interesting issue is the effect of the BMS decision on foreign defendants.  Justice Sotomayor may well be right that foreign defendants neither incorporated nor having a principal place of business in the United States will be free from most national litigation brought in a single State forum because they will not be subject to general personal jurisdiction anywhere in the country.  But if the foreign defendant has committed acts in a State allegedly giving rise to national injury, such suits may still be possible.  And foreign companies should also bear in mind that a special federal rule (Fed. R. Civ. P. 4(k)(2)) already makes them amenable to suit anywhere in the United States for alleged violations of federal law, if their contacts with the United States in the aggregate satisfy the "minimum contacts" standard, and there is no other U.S. forum where the contacts are sufficient to support jurisdiction.

In summary, whether and how the BMS opinion will be applied to federal antitrust and State antitrust class action claims remains to be seen and is likely to be litigated in pending cases.


[1] No. 16–466, 2017 WL 2621322 (June 19, 2017).

[2] Id. at *4.

[3] Id. at *4-5.

[4] Id. at *4 (citation omitted).

[5] See Daimler AG v. Bauman, 134 S. Ct. 746, 754 (2014); International Shoe Co. v. Washington, 326 U.S. 310, 316 (1945).

[6] Bristol-Myers Squibb Co., 2017 WL 2621322, at *8.

[7] Id. at *10.

[8] Bristol-Myers Squibb Company v. Superior Court, 377 P.3d 874, 889 (Cal. 2016).

[9] Id. at 889-890.

[10] Bristol-Myers Squibb Co., 2017 WL 2621322, at *8.

[11] Id. at *7-11.

[12] Id. at *10.

[13] Id. at *16 (citing International Shoe Co. v. Washington, 326 U.S. 310, 316 (1945)).

[14] Id. at *14.

[15] See St. Joe Paper Co v. Superior Court, 120 Cal. App. 3d 991, 997-98 (1981) (citing Maricopa County v. American Petrofina, Inc., 322 F. Supp. 467 (N.D. Cal. 1971), for the proposition that "if a person engages in an out-of-state conspiracy that is designed to and affects the prices charged in the forum state, the forum state has jurisdiction of the conspirators").

[16] See, e.g.,Gutierrez v. Givens, 1 F. Supp. 2d 1077, 1083 n.1 (S.D. Cal. 1998).

[17] See, e.g., Fenerjian v. Nong Shim Co., Ltd., No. 13-cv-04115-WHO, 2015 WL 13000357, at *4 (N.D. Cal. Mar. 30, 2015).

[18] See, e.g.,KM Enterprises, Inc. v. Global Traffic Tech., Inc., 725 F.3d 718, 724 (7th Cir. 2013); Carrier Corp. v. Outokumpu Oyj, 673 F.3d 430, 450 (6th Cir. 2012).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
16 Oct 2019, Speaking Engagement, Dusseldorf, Germany

EQS Group in cooperation with Orrick, Herrington & Sutcliffe LLP invites you to their event on investor relations and compliance. Topics include ESEF reporting and how to meet the challenges of the Europe-wide XBRL format from 2020 onwards.

16 Oct 2019, Webinar, New York, United States

Two years after the start of the #MeToo movement, multinational companies are still navigating the movement's impact on the workplace and corporate reputational risk.

29 Oct 2019, Speaking Engagement, Washington, United States

On Friday, November 1, 2019 from 11:45 AM - 12:45 PM, Lorraine McGowen will speak on the “When the Weak Link Breaks: Supply Chain Insolvencies – Automotive and Elsewhere” panel.

Similar Articles
Relevancy Powered by MondaqAI
Skadden, Arps, Slate, Meagher & Flom (UK) LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Skadden, Arps, Slate, Meagher & Flom (UK) LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions